Retransplantation Outcomes at a Large Lung Transplantation Program.

Area of Science:

• Thoracic Surgery
• Transplant Immunology
• Pulmonary Medicine

Background:

• Lung retransplantation (ReTX) is increasingly necessary due to rising primary lung transplant volumes.
• Characterizing ReTX patient outcomes is essential for improving care.
• This study analyzes ReTX survival at a major U.S. transplant center.

Purpose of the Study:

• To investigate and characterize covariates associated with lung ReTX survival.
• To identify factors influencing mortality in lung retransplant recipients.

Main Methods:

• Analysis of demographic, clinical diagnoses, and comorbidity data.
• Kaplan-Meier survival analysis for 30-day and 3-year outcomes.
• Cox proportional modeling to identify mortality predictors.

Main Results:

• Of 684 lung transplants, 49 were ReTX; ReTX patients were younger (median 49 vs 62 years) but had higher LAS (46.2 vs 37.0).
• ReTX, older age, female sex, prolonged hospitalization, reduced GFR, shorter 6MWD, and smaller donor/recipient height ratio predicted decreased survival.
• Chronic graft rejection was the primary cause of death in long-term ReTX survivors.

Conclusions:

• Lung retransplant recipients demonstrate significantly poorer long-term survival.
• Lung ReTX should be reserved for highly selected patient candidates.